BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30
• 31

• Press Releases

  Atea Pharmaceuticals to Present New Data Supporting the Combination of Bemnifosbuvir and Ruzasvir for the Treatment of Hepatitis C Virus at AASLD’s The Liver Meeting 2024

  October 30, 2024

   · 

  6 min read
• Press Releases

  Chemomab Therapeutics to Report Third Quarter 2024 Financial Results and Provide a Business Update

  October 30, 2024

   · 

  1 min read
• Press Releases

  Larimar Therapeutics Reports Third Quarter 2024 Operating and Financial Results

  October 30, 2024

   · 

  13 min read
• Press Releases

  KITHER BIOTECH ANNOUNCES PHASE 1 CLINICAL STUDY OF KIT2014, A NOVEL INHALED PEPTIDE THERAPY FOR CYSTIC FIBROSIS

  October 30, 2024

   · 

  3 min read
• Press Releases

  Neurocrine Biosciences Reports Third Quarter 2024 Financial Results and Raises 2024 INGREZZA Sales Guidance

  October 30, 2024

   · 

  17 min read
• Press Releases

  TerraPower Announces Strategic Agreement to Commercialize and Purchase HALEU

  October 30, 2024

   · 

  3 min read
• Press Releases

  Novocure Reports Third Quarter 2024 Financial Results

  October 30, 2024

   · 

  11 min read
• Press Releases

  HOOKIPA Pharma Doses First Patients with Eseba-vec as Adjuvant Therapy in Phase 2 Investigator Lead Trial for Head & Neck Cancer

  October 30, 2024

   · 

  7 min read
• Press Releases

  MacroGenics Announces Leadership Transition

  October 30, 2024

   · 

  6 min read
• Press Releases

  COUR Pharmaceuticals Doses First Patient in Phase 1b/2a Clinical Trial Evaluating CNP-106 in Generalized Myasthenia Gravis

  October 30, 2024

   · 

  2 min read